Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumors

被引:15
作者
Steigen, Sonja E. [1 ,3 ,4 ]
Straume, Bjorn [2 ]
Turbin, Dmitry [4 ]
Chan, Andy K. W. [3 ,4 ]
Leung, Samuel [3 ,4 ]
Nielsen, Torsten . [3 ,4 ]
Lindal, Sigurd
机构
[1] Univ Tromso, Dept Pathol, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Community Med, Tromso, Norway
[3] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada
[4] Univ British Columbia, Genet Pathol Evaluat Ctr, Vancouver, BC, Canada
关键词
gastrointestinal stromal tumor; morphometry; roundness;
D O I
10.1369/jhc.7A7333.2007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms found in the gastrointestinal tract. The purpose of this study was to evaluate whether morphometric measurements could complement tumor size and mitotic activity in risk evaluation. Nuclear roundness and ellipse axis ratio were found to correlate with tumor size, mitotic activity, nuclear atypia, and hemorrhage. Morphometric variables in 422 GISTs were significant for overall survival in univariate analyses but did not retain independent significance in multivariate analyses incorporating mitotic count and tumor size. Traditional variables, together with sex, location of primary tumor, and nuclear atypia, seem to be the best parameters for prognostic evaluation.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 24 条
[1]   NUCLEAR MORPHOMETRY IN THE DETERMINATION OF THE PROGNOSIS OF MARKED ATYPICAL ENDOMETRIAL HYPERPLASIA [J].
AUSEMS, EWMA ;
VANDERKAMP, JK ;
BAAK, JPA .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1985, 4 (03) :180-185
[2]   Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias [J].
Baak, JPA ;
Orbo, A ;
van Diest, PJ ;
Jiwa, M ;
de Bruin, P ;
Broeckaert, M ;
Snijders, W ;
Boodt, PJ ;
Fons, G ;
Burger, C ;
Verheijen, RHM ;
Houben, PWH ;
The, HS ;
Kenemans, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (07) :930-935
[3]   Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors [J].
Carrillo, R ;
Candia, A ;
RodriguezPeralto, JL ;
Caz, V .
HUMAN PATHOLOGY, 1997, 28 (02) :160-165
[4]   PREDICTING PROGNOSIS OF GASTROINTESTINAL SMOOTH-MUSCLE TUMORS - ROLE OF CLINICAL AND HISTOLOGIC EVALUATION, FLOW-CYTOMETRY, AND IMAGE CYTOMETRY [J].
CUNNINGHAM, RE ;
FEDERSPIEL, BH ;
MCCARTHY, WF ;
SOBIN, LH ;
OLEARY, TJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (06) :588-594
[5]   Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation [J].
Debiec-Rychter, M ;
Lasota, J ;
Sarlomo-Rikala, M ;
Kordek, R ;
Miettinen, M .
CANCER GENETICS AND CYTOGENETICS, 2001, 128 (01) :24-30
[6]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[7]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[8]   Prognosis of gastrointestinal smooth-muscle (Stromal) tumors - Dependence on anatomic site [J].
Emory, TS ;
Sobin, LH ;
Lukes, L ;
Lee, DH ;
O'Leary, TJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) :82-87
[9]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
HUMAN PATHOLOGY, 2002, 33 (05) :459-465
[10]  
Hoque A, 2001, CANCER EPIDEM BIOMAR, V10, P249